The Risk/Benefit Analysis of Oral Anticoagulant Treatment in Atrial Fibrillation Using HAS-BLED and CHA2DS2-VASc Score

1. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). Circulation. 2001;104: 2118-2150.10.1161/circ.104.17.2118Search in Google Scholar

2. Guidelines for the management of atrial fibrillation. European Heart Journal. 2010;31: 2369–2429.10.1093/eurheartj/ehq27820802247Search in Google Scholar

3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine. 2007;146: 857-867.10.7326/0003-4819-146-12-200706190-0000717577005Search in Google Scholar

4. Camm AJ, Lip GY, De Caterina R et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. European Heart Journal. 2012;33:2719-2747.Search in Google Scholar

5. Pisters R, Lane DA, de Vos CB et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey. Chest. 2010;138(5):1093-1100.10.1378/chest.10-013420299623Search in Google Scholar

6. Thrift AG, Donnan GA, Mc Neil JJ. Epidemiology of intracranial hemorrhage. Epidemiologic Reviews. 1995;17:361-381.10.1093/oxfordjournals.epirev.a0361998654517Search in Google Scholar

7. Kase CS. Intracerebral hemorrhage. Baillière’s Clinical Neurology. 1995;4:247-278.Search in Google Scholar

8. Shorr RL, Ray WA, Daugherty JR et al. Concurrent use of nonsteroidal anti-inflammatory drugs and oral anticoagulants places elderly persons at high risk of hemorrhagic peptic ulcer disease. Annals of Internal Medicine. 1993;153:1665-1670.10.1001/archinte.1993.00410140047006Search in Google Scholar

9. Eva Prescott, Rikke Sørensen. Female sex as a risk factor for stroke in atrial fibrillation. British Medical Journal. 2012;344:e3789.10.1136/bmj.e378922653983Search in Google Scholar

10. Avgil TM, Jackevicius CA, Rahme E et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. The Journal of the American Medical Association. 2012;307:1952-1958.10.1001/jama.2012.349022570463Search in Google Scholar

11. Dagres N, Nieuwlaat R, Vardas PE et al. Gender-related differences in presentation, treatment and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. Journal of the American College of Cardiology. 2007; 49:572-577.10.1016/j.jacc.2006.10.04717276181Search in Google Scholar

12. Flaherty MLKB, Woo D, Kleindorfer D et al. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007;68:116-121.10.1212/01.wnl.0000250340.05202.8b17210891Search in Google Scholar

13. Geraint Fuller, Mark Manford. Neurology: An illustrated colour text, Churchill Livingstone Elsevier. Philadelphia. 2006;70-71.Search in Google Scholar

14. Sacco RL, Foulkes MA, Mohr JP et al. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke. 1989;20:983-989.10.1161/01.STR.20.8.983Search in Google Scholar

15. Sacco RL, Shi T, Zamanillo MC et al. Predictors of mortality and recurrence after hospitalised cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology. 1994;44:626-634.10.1212/WNL.44.4.626Search in Google Scholar

16. Hallas J, Dall M, Andersen BS et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. British Medical Journal. 2006;333:726.10.1136/bmj.38947.697558.AESearch in Google Scholar

17. Sørensen R, Hansen ML, Abildstrom SZ et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data. The Lancet. 2009;374:1967-1974.10.1016/S0140-6736(09)61751-7Search in Google Scholar

18. Saour JN, Sieck JO, Mamo LA et al. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. New England Journal of Medicine. 1990;322:428-432.10.1056/NEJM199002153220703Search in Google Scholar

19. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. The Lancet. 1996;348:423-428.10.1016/S0140-6736(96)01109-9Search in Google Scholar

20. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Annals of Internal Medicine. 1994;120:897-902.10.7326/0003-4819-120-11-199406010-000018172435Search in Google Scholar